Thermo Fisher Scientific Inc.
TMO
$508.47
-$3.75-0.73%
| 12/31/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.57B | 6.65B | 8.82B | 7.25B | 8.08B |
| Total Receivables | 9.63B | 9.80B | 9.43B | 9.35B | 9.66B |
| Inventory | 4.98B | 5.43B | 5.20B | 5.13B | 5.09B |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.96B | 1.91B | 2.03B | 1.90B | 1.76B |
| Total Current Assets | 22.14B | 23.78B | 25.48B | 23.64B | 24.59B |
|
|
|||||
| Total Current Assets | 22.14B | 23.78B | 25.48B | 23.64B | 24.59B |
| Net Property, Plant & Equipment | 10.80B | 9.41B | 9.28B | 9.32B | 11.00B |
| Long-term Investments | 45.85B | 46.73B | 43.84B | 43.84B | 44.02B |
| Goodwill | 45.85B | 46.73B | 43.84B | 43.84B | 44.02B |
| Total Other Intangibles | 15.57B | 16.26B | 15.52B | 16.05B | 16.71B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.89B | 4.09B | 3.90B | 4.02B | 2.37B |
| Total Assets | 97.32B | 100.36B | 98.50B | 97.10B | 98.73B |
|
|
|||||
| Total Accounts Payable | 3.08B | 2.61B | 2.55B | 2.56B | 2.87B |
| Total Accrued Expenses | 4.88B | 5.16B | 4.46B | 4.25B | 4.52B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.48B | 4.12B | 5.12B | 4.45B | 3.87B |
| Total Finance Division Other Current Liabilities | 2.90B | 2.72B | 2.64B | 2.68B | 2.75B |
| Total Other Current Liabilities | 2.90B | 2.72B | 2.64B | 2.68B | 2.75B |
| Total Current Liabilities | 13.33B | 14.60B | 14.77B | 13.94B | 14.01B |
|
|
|||||
| Total Current Liabilities | 13.33B | 14.60B | 14.77B | 13.94B | 14.01B |
| Long-Term Debt | 28.93B | 31.20B | 30.10B | 31.00B | 31.41B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.43B | 200.00M | 207.00M | 215.00M | 1.43B |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.96B | 5.27B | 5.88B | 6.32B | 5.03B |
| Total Liabilities | 47.65B | 51.27B | 50.96B | 51.47B | 51.88B |
|
|
|||||
| Common Stock & APIC | 18.41B | 18.28B | 18.09B | 17.93B | 17.73B |
| Retained Earnings | 53.10B | 51.42B | 49.94B | 48.54B | 47.36B |
| Treasury Stock & Other | -21.92B | -20.70B | -20.60B | -20.95B | -18.36B |
| Total Common Equity | 49.58B | 48.99B | 47.43B | 45.52B | 46.74B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 49.58B | 48.99B | 47.43B | 45.52B | 46.74B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 87.00M | 107.00M | 103.00M | 107.00M | 107.00M |
| Total Equity | 49.67B | 49.10B | 47.54B | 45.62B | 46.84B |
|
|
|||||
